Aday Jacob S, Davis Alan K, Mitzkovitz Cayla M, Bloesch Emily K, Davoli Christopher C
Department of Psychology, Central Michigan University, 1200 South Franklin Street, Mount Pleasant, Michigan 48859, United States.
College of Social Work, The Ohio State University, 1947 College Road, Columbus, Ohio 43210, United States.
ACS Pharmacol Transl Sci. 2021 Mar 5;4(2):424-435. doi: 10.1021/acsptsci.1c00014. eCollection 2021 Apr 9.
Psychedelic drugs are increasingly being incorporated into therapeutic contexts for the purposes of promoting mental health. However, they can also induce adverse reactions in some individuals, and it is difficult to predict before treatment who is likely to experience positive or adverse acute effects. Although consideration of setting and dosage as well as excluding individuals with psychotic predispositions has thus far led to a high degree of safety, it is imperative that researchers develop a more nuanced understanding of how to predict individual reactions. To this end, the current systematic review coalesced the results of 14 studies that included baseline states or traits predictive of the acute effects of psychedelics. Individuals high in the traits of absorption, openness, and acceptance as well as a state of surrender were more likely to have positive and mystical-type experiences, whereas those low in openness and surrender or in preoccupied, apprehensive, or confused psychological states were more likely to experience acute adverse reactions. Participant sex was not a robust predictor of drug effects, but 5-HT2AR binding potential, executive network node diversity, and rACC volume may be potential baseline biomarkers related to acute reactions. Finally, increased age and experience with psychedelics were individual differences related to generally less intense effects, indicating that users may become slightly less sensitive to the effects of the drugs after repeated usage. Although future well-powered, placebo-controlled trials directly comparing the relative importance of these predictors is needed, this review synthesizes the field's current understanding of how to predict acute reactions to psychedelic drugs.
迷幻药物越来越多地被用于治疗环境中以促进心理健康。然而,它们也可能在一些个体中引发不良反应,并且在治疗前很难预测谁可能会经历积极或不良的急性效应。尽管迄今为止,考虑环境、剂量以及排除有精神病倾向的个体已带来了高度的安全性,但研究人员必须对如何预测个体反应形成更细致入微的理解。为此,当前的系统综述汇总了14项研究的结果,这些研究包括了预测迷幻药物急性效应的基线状态或特征。在吸收性、开放性、接纳性以及一种臣服状态等特质方面得分高的个体更有可能有积极的和神秘类型的体验,而那些开放性和臣服性得分低或处于全神贯注、焦虑或困惑心理状态的个体更有可能经历急性不良反应。参与者的性别并非药物效应的可靠预测指标,但5-HT2AR结合潜力、执行网络节点多样性和前扣带回皮质体积可能是与急性反应相关的潜在基线生物标志物。最后,年龄增长和有迷幻药物使用经历是与效应总体上不那么强烈相关的个体差异,这表明使用者在反复使用后可能对药物效应的敏感性会略有降低。尽管未来需要进行有充足样本量、安慰剂对照的试验来直接比较这些预测指标的相对重要性,但本综述综合了该领域目前对如何预测对迷幻药物急性反应的理解。